BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $971,179 | -3.0% | 19,339 | +22.1% | 0.00% | – |
| Q2 2023 | $1,001,246 | +63.0% | 15,843 | +16.1% | 0.00% | – |
| Q1 2023 | $614,091 | +6.5% | 13,650 | +3.7% | 0.00% | – |
| Q4 2022 | $576,583 | -39.2% | 13,161 | -8.6% | 0.00% | -100.0% |
| Q3 2022 | $948,000 | +35.2% | 14,393 | +3.8% | 0.00% | – |
| Q2 2022 | $701,000 | -12.8% | 13,872 | +10.2% | 0.00% | – |
| Q1 2022 | $804,000 | -46.3% | 12,592 | -10.0% | 0.00% | -100.0% |
| Q4 2021 | $1,498,000 | -15.2% | 13,985 | -18.6% | 0.00% | 0.0% |
| Q3 2021 | $1,767,000 | +21.7% | 17,185 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $1,452,000 | +3.1% | 16,507 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $1,408,000 | +4.5% | 14,485 | +20.5% | 0.00% | 0.0% |
| Q4 2020 | $1,348,000 | +35.6% | 12,024 | +12.1% | 0.00% | 0.0% |
| Q3 2020 | $994,000 | -16.8% | 10,725 | -29.9% | 0.00% | 0.0% |
| Q2 2020 | $1,194,000 | – | 15,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |